New treatment for infected heart device: quick re-implant
Part of Heart & circulation, Infections clinical trials.
This trial tests if a new, faster approach to replacing an infected pacemaker or defibrillator is safe. If you have a heart device infection and meet recovery milestones, you might be able to get a new device sooner than usual.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed infection of your pacemaker or defibrillator.
- Your doctor says the device must be removed.
- You need a new device after removal.
- You have received at least 3 days of effective antibiotics.
- Your infection is responding to treatment, shown by negative blood cultures, lower white blood cell count, and lower CRP levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding bacteriophages (viruses that kill bacteria) to standard antibiotic treatment can help people with a serious heart valve infection called infective endocarditis. It may offer a new way to fight the infection.
This trial compares removing a heart device (like a pacemaker) versus using antibiotics and other medical care to treat an infection. It may help doctors decide the best way to handle infections related to these devices.
This trial studies whether people with an implanted heart device infection should take antibiotics for life or stop antibiotics and monitor closely. It is for situations where doctors think removing the device is not a safe or suitable option.
This trial tests whether a shorter course of antibiotics is as safe and effective as the standard longer course for people who have had an infected heart device removed. It aims to reduce side effects and make treatment easier.
This study is testing an approach to improve how clinicians care for people with suspected infections around an implanted heart device (like a pacemaker or defibrillator). It may help ensure the infection is recognized and treated appropriately, especially when device removal (extraction) might be needed.
This study tests a new antibiotic called oritavancin for treating skin infections at the site of heart devices like pacemakers or defibrillators, especially when caused by drug-resistant bacteria. The goal is to see if this once-daily antibiotic works as well as the standard treatment.
Hear when a new Endocarditis, Bacterial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.